203 related articles for article (PubMed ID: 35716883)
1. On the size-regulation of RNA-loaded lipid nanoparticles synthesized by microfluidic device.
Okuda K; Sato Y; Iwakawa K; Sasaki K; Okabe N; Maeki M; Tokeshi M; Harashima H
J Control Release; 2022 Aug; 348():648-659. PubMed ID: 35716883
[TBL] [Abstract][Full Text] [Related]
2. Development of a Microfluidic-Based Post-Treatment Process for Size-Controlled Lipid Nanoparticles and Application to siRNA Delivery.
Kimura N; Maeki M; Sato Y; Ishida A; Tani H; Harashima H; Tokeshi M
ACS Appl Mater Interfaces; 2020 Jul; 12(30):34011-34020. PubMed ID: 32667806
[TBL] [Abstract][Full Text] [Related]
3. Hydrophobic scaffolds of pH-sensitive cationic lipids contribute to miscibility with phospholipids and improve the efficiency of delivering short interfering RNA by small-sized lipid nanoparticles.
Sato Y; Okabe N; Note Y; Hashiba K; Maeki M; Tokeshi M; Harashima H
Acta Biomater; 2020 Jan; 102():341-350. PubMed ID: 31733331
[TBL] [Abstract][Full Text] [Related]
4. Elucidation of the physicochemical properties and potency of siRNA-loaded small-sized lipid nanoparticles for siRNA delivery.
Sato Y; Note Y; Maeki M; Kaji N; Baba Y; Tokeshi M; Harashima H
J Control Release; 2016 May; 229():48-57. PubMed ID: 26995758
[TBL] [Abstract][Full Text] [Related]
5. Understanding the Manufacturing Process of Lipid Nanoparticles for mRNA Delivery Using Machine Learning.
Sato S; Sano S; Muto H; Kubara K; Kondo K; Miyazaki T; Suzuki Y; Uemoto Y; Ukai K
Chem Pharm Bull (Tokyo); 2024; 72(6):529-539. PubMed ID: 38839372
[TBL] [Abstract][Full Text] [Related]
6. Importance of Process Parameters Influencing the Mean Diameters of siRNA-Containing Lipid Nanoparticles (LNPs) on the in Vitro Activity of Prepared LNPs.
Nakamura K; Aihara K; Ishida T
Biol Pharm Bull; 2022; 45(4):497-507. PubMed ID: 35370275
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Size and Charge of Lipid Nanoparticles Prepared by Microfluidic Mixing on Their Lymph Node Transitivity and Distribution.
Nakamura T; Kawai M; Sato Y; Maeki M; Tokeshi M; Harashima H
Mol Pharm; 2020 Mar; 17(3):944-953. PubMed ID: 31990567
[TBL] [Abstract][Full Text] [Related]
8. mRNA-Loaded Lipid Nanoparticles Targeting Dendritic Cells for Cancer Immunotherapy.
Sasaki K; Sato Y; Okuda K; Iwakawa K; Harashima H
Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 36015198
[TBL] [Abstract][Full Text] [Related]
9. Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery.
Maeki M; Uno S; Niwa A; Okada Y; Tokeshi M
J Control Release; 2022 Apr; 344():80-96. PubMed ID: 35183654
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of Polymer-Lipid Nanoparticles by Microfluidic Focusing for siRNA Delivery.
Li Y; Huang X; Lee RJ; Qi Y; Wang K; Hao F; Zhang Y; Lu J; Meng Q; Li S; Xie J; Teng L
Molecules; 2016 Oct; 21(10):. PubMed ID: 27763492
[TBL] [Abstract][Full Text] [Related]
11. One-Step Production Using a Microfluidic Device of Highly Biocompatible Size-Controlled Noncationic Exosome-like Nanoparticles for RNA Delivery.
Kimura N; Maeki M; Ishida A; Tani H; Tokeshi M
ACS Appl Bio Mater; 2021 Feb; 4(2):1783-1793. PubMed ID: 35014524
[TBL] [Abstract][Full Text] [Related]
12. Production of siRNA-Loaded Lipid Nanoparticles using a Microfluidic Device.
Maeki M; Okada Y; Uno S; Niwa A; Ishida A; Tani H; Tokeshi M
J Vis Exp; 2022 Mar; (181):. PubMed ID: 35404350
[TBL] [Abstract][Full Text] [Related]
13. Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers.
Maeki M; Fujishima Y; Sato Y; Yasui T; Kaji N; Ishida A; Tani H; Baba Y; Harashima H; Tokeshi M
PLoS One; 2017; 12(11):e0187962. PubMed ID: 29182626
[TBL] [Abstract][Full Text] [Related]
14. Single pot organic solvent-free thermocycling technology for siRNA-ionizable LNPs: a proof-of-concept approach for alternative to microfluidics.
De A; Ko YT
Drug Deliv; 2022 Dec; 29(1):2644-2657. PubMed ID: 35949146
[TBL] [Abstract][Full Text] [Related]
15. 3D-printed microfluidic device for high-throughput production of lipid nanoparticles incorporating SARS-CoV-2 spike protein mRNA.
Lin WS; Bostic WKV; Malmstadt N
Lab Chip; 2024 Jan; 24(2):162-170. PubMed ID: 38165143
[TBL] [Abstract][Full Text] [Related]
16. Microfluidic assembly of lipid-based oligonucleotide nanoparticles.
Yu B; Zhu J; Xue W; Wu Y; Huang X; Lee LJ; Lee RJ
Anticancer Res; 2011 Mar; 31(3):771-6. PubMed ID: 21498694
[TBL] [Abstract][Full Text] [Related]
17. Microfluidic production of mRNA-loaded lipid nanoparticles for vaccine applications.
Lopes C; Cristóvão J; Silvério V; Lino PR; Fonte P
Expert Opin Drug Deliv; 2022 Oct; 19(10):1381-1395. PubMed ID: 36223174
[TBL] [Abstract][Full Text] [Related]
18. Chemistry of Lipid Nanoparticles for RNA Delivery.
Eygeris Y; Gupta M; Kim J; Sahay G
Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
[TBL] [Abstract][Full Text] [Related]
19. Impact of non-ionizable lipids and phase mixing methods on structural properties of lipid nanoparticle formulations.
Pratsinis A; Fan Y; Portmann M; Hammel M; Kou P; Sarode A; Ringler P; Kovacik L; Lauer ME; Lamerz J; Hura GL; Yen CW; Keller M
Int J Pharm; 2023 Apr; 637():122874. PubMed ID: 36948476
[TBL] [Abstract][Full Text] [Related]
20. A tale of nucleic acid-ionizable lipid nanoparticles: Design and manufacturing technology and advancement.
De A; Ko YT
Expert Opin Drug Deliv; 2023 Jan; 20(1):75-91. PubMed ID: 36445261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
